Development of COVID-19 treatment by IFN response caused by TRIM39R
- Funded by KAKENHI
- Total publications:0 publications
Grant number: 21K06566
Grant search
Key facts
Disease
COVID-19Start & end year
20212024Known Financial Commitments (USD)
$37,440Funder
KAKENHIPrincipal Investigator
Riho Kurata UnspecifiedResearch Location
JapanLead Research Institution
Osaka Medical College of PharmacyResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable